Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Cancer risk in relatives of patients with common colorectal cancer

Article Abstract:

First-degree relatives of patients with common colorectal cancer may have a higher risk of developing this type of cancer than other individuals. A study compared the incidence of colorectal cancer among 7,493 first-degree relatives and 1,015 spouses of 523 colorectal cancer patients and 523 healthy individuals. The risk of developing colorectal cancer was twice as high for parents and siblings of colorectal cancer patients than for those of healthy individuals. This risk was higher for individuals with two first-degree relatives with colorectal cancer than for those with only one. The cumulative risk was higher among first-degree relatives of patients who were under 45 years old at the time of diagnosis. First-degree relatives of colorectal cancer patients should consider having routine screening for colorectal cancer beginning at the age of 40 years old.

Author: Hopper, John L., St. John, D. James B., McDermott, Francis T., Debney, Elizabeth A., Johnson, William R., Hughes, Edward S.R.
Publisher: American College of Physicians
Publication Name: Annals of Internal Medicine
Subject: Health
ISSN: 0003-4819
Year: 1993
Risk factors, Colorectal cancer, Genetic aspects, Cancer, Cancer genetics

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Lessons learned from attempts to establish the blind in placebo-controlled trials of zinc for the common cold

Article Abstract:

All researchers who conduct placebo-controlled trials should ask the patients in the trial to guess whether they are receiving the drug or the placebo. A placebo is an inactive substance that supposedly looks and tastes exactly like the drug. Asking patients to guess which one they're receiving would detect any differences.

Author: Desbiens, Norman A.
Publisher: American College of Physicians
Publication Name: Annals of Internal Medicine
Subject: Health
ISSN: 0003-4819
Year: 2000
Editorial, Research, Placebos

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Zinc acetate lozenges to treat the common cold

Article Abstract:

Zinc lozenges may substantially shorten the duration of a cold, according to a study of 50 people. Those who took zinc lozenges within 24 hours of symptoms got over the cold in about 4 days, compared to 8 days in the group that took a placebo, or inactive substance.

Publisher: American College of Physicians
Publication Name: Annals of Internal Medicine
Subject: Health
ISSN: 0003-4819
Year: 2000

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Health aspects, Care and treatment, Cold (Disease), Common cold, Zinc compounds
Similar abstracts:
  • Abstracts: Impaired tumoricidal function of alveolar macrophages from patients with non-small cell lung cancer. Insulitis in type 1 (insulin-dependent) diabetes mellitus in man - macrophages, lymphocytes and interferon-gamma containing cells
  • Abstracts: Dental implants placed in a patient with multiple myeloma: report of case. High-quality research and patient care: an overview of clinical trials
  • Abstracts: Supporting patients with Crohn's disease. Essential support. Support for Tony's Crohn's
  • Abstracts: Bladder cancer - field versus clonal origin. Prevention of bladder cancer. A 32-year-old man with a lesion of the urinary bladder
  • Abstracts: Timing of antiretroviral therapy initiation in tuberculosis patients with AIDS. Association between insulin resistance and hepatitis C virus chronic infection in HIV-hepatitis C virus-coinfected patients undergoing antiretroviral therapy
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.